Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of
cellular metabolism to treat cancer and genetically defined
diseases, today announced that the company is scheduled to present
at the virtual 39th Annual J.P. Morgan Healthcare Conference on
Monday, January 11, 2021 at 10:50 a.m. ET.
A live webcast of the presentation and breakout session can be
accessed under "Events & Presentations" in the Investors
section of the company's website at www.agios.com. A replay of the
webcast will be archived on the Agios website for at least two
weeks following the presentation.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat malignant
hematology, solid tumors and genetically defined diseases through
scientific leadership in the field of cellular metabolism. In
addition to an active research and discovery pipeline across these
three therapeutic areas, Agios has two approved oncology precision
medicines and multiple first-in-class investigational therapies in
clinical and/or preclinical development. For more information,
please visit the company's website at www.agios.com.
Investors:Holly Manning, 617-844-6630Director,
Media:Jessica Rennekamp, 857-209-3286Associate
Director, Corporate CommunicationsJessica.Rennekamp@agios.com